Medical Weight Loss for Glen Burnie, Maryland Residents
Glen Burnie, Maryland residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Glen Burnie through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Glen Burnie Residents Choose New Hope Weight Loss
Glen Burnie patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Maryland and beyond since 2020.
From our Costa Mesa, California practice, we provide Glen Burnie with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
In Glen Burnie, Maryland, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Glen Burnie and the greater Anne Arundel County area south of Baltimore. Whether you are starting your first GLP-1 program or switching from a brand medication, your Glen Burnie treatment plan is built around your health history and goals.
Whether you live in central Glen Burnie or its outskirts, you get exactly the same care and the same price. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Glen Burnie
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Glen Burnie
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Glen Burnie address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Glen Burnie
How do I get treatment from Glen Burnie?
As a Glen Burnie, Maryland patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Glen Burnie?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Glen Burnie in cold-pack packaging, no lines and no drive.
How much does it cost for Glen Burnie patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Glen Burnie do you serve?
We serve patients from across Glen Burnie by telehealth, including Glen Burnie and the greater Anne Arundel County area south of Baltimore.
What support is there for side effects for Glen Burnie patients?
Dr. Sharma starts Glen Burnie patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Glen Burnie, Maryland by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.